- Investing Ideas
- Canadian Pharmaceuticals & Biotech Healthy potentially undervalued
Canadian Pharmaceuticals & Biotech Healthy potentially undervalued
Results
8
Companies which are potentially undervalued and in an acceptable financial position.
8 companies
High Tide
Market Cap: CA$288.3m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.28
7D
2.2%
1Y
2.5%
Verano Holdings
Market Cap: CA$590.2m
Engages in the cannabis business in the United States.
VRNO
CA$1.62
7D
3.2%
1Y
105.1%
Aurora Cannabis
Market Cap: CA$285.8m
Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
ACB
CA$5.04
7D
4.8%
1Y
-13.3%
Green Thumb Industries
Market Cap: CA$2.1b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$9.22
7D
-0.9%
1Y
27.7%
Decibel Cannabis
Market Cap: CA$77.9m
An integrated cannabis company, engages in the cannabis cultivation in Canada.
DB
CA$0.14
7D
8.0%
1Y
125.0%
Cresco Labs
Market Cap: CA$573.4m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.26
7D
0%
1Y
43.2%
Trulieve Cannabis
Market Cap: CA$1.7b
Operates as a cannabis retailer in the United States.
TRUL
CA$8.72
7D
0.1%
1Y
68.3%
Medexus Pharmaceuticals
Market Cap: CA$127.1m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$3.97
7D
-1.2%
1Y
57.5%